Borderline hypertension attracts investigative interest since it is an early predictor of established hypertension and its sequelae. This condition offers the opportunity of studying arterial hypertension at its inception, before the development of secondary pressure-related changes. A number of abnormalities of the circulation have been described in borderline hypertension. The peripheral resistance is either elevated or inappropriately adjusted to the prevailing increased cardiac output and blood flow. Cardiac output, heart rate and stroke volume are elevated in a proportion of patients. Decreased plasma volume, enhanced pressor responsiveness and elevated plasma renin activity have also been noted. All these changes could hypothetically be explained by a neurogenic mechanism. Although the experimental evidence supporting a neurogenic origin of borderline hypertension is incomplete and often indirect, most findings point toward an abnormal autonomic control of the circulation in this disorder.
Borderline hypertension attracts investigative interest since it appears to be an early predictor of future established hypertension (Fig.  l) .l This is a finding that has been amply confirmed.2 Furthermore, borderline hypertension carries an excess of overall mortality (Fig. 2)'p3m5 and specific cardiovascular morbidity (Fig. 3 ).6-s
As arterial hypertension develops, many secondary cardiovascular changes occur. Resetting of arterial baroreceptors,lOJ1 restructuring of resistance vessels12J3 and alteration in cardiac performance14Js are examples. Therefore, observations on the pathophysiology of established hypertension need to be subjected to close scrutiny to determine whether thev are related to the initiation of the nressure elevation or are a secondary consequence of the high blood dressure.
This problem is obviated in borderline hypertension. The advantage of studying very mild hypertension before the development of secondary pressure-related changes is self-evident, but limitations risk for future hypertension is higher than in the general population, not all patients will later have sustained hypertension.
While assessing the significance of the abnormalities in autonomic nervous system function in borderline hypertension one must keep in mind, the advantages and limitations of borderline hypertension as a model of sustained hypertension. trates the hypothesis that most of the observed aberrations in borderline hypertension can be explained h?* (I neurogpnic mechanism. Whereas one can draw logical and conceptual support for this hypothesis, Figure 4 also illustrates that, in our assessment, support,ive facts are neither always available nor invariablv strong. A detailed review of the evidence for and against the role of the nervous system in borderline hypertension follows.
Neurogenic Borderline HypertensionTesting a Hypothesis

Biochemical indexes of Overall Sympathetic Nervous System Activity
Attempts have been made t,o utilize the biochemi-(~11 events accompanying sympathetic nervous discharge to quantitate overall sympathetic nervous activity in man. This has been done by measuring the concentration in plasma or excretion in urine of norepinephrine, dopamine-beta-hydroxylase and cyclic adenosine monophosphate. Findings in borderline hypertension will he presented.
Catecholamines:
Plasma epinephrine has its origins in the secretions of t,he adrenal medulla. Norepinephrine is t,he neurotransmitter of the sympathetic nerves, but is released also from the adrenal medulla. However. the sympathetic nerves, particularly of t,he heart."" are thought to be the major source of plasma norepinephrine.
Norepinephrine released from sympathetic nerve terminals produces postsynaptic excitation, and is *'inactivated" by several different methods, including active reuptake into the nerve terminal, diffusion into the blood, and to some extent local enzymatic destruction by catechol-o-methyltransferase.55 Plasma levels of norepinephrine are determined by the amount of transmitter released, the activity of the local mechanisms of neuronal reuptake and enzymatic degradation, the rate of diffusion into the circulation. and the rate of extraction of norepinephrine from plasma. Despite the multiplicity of factors pot entially influencing norepinephrine levels, there is good evidence that the plasma norepinephrine con- To what extent the urinary excretion of catecholamines in man reflects plasma catecholamine concentrations remains something of an open question. Although the assumption is often made that epinephrine and norepinephrine excretion in urine is a function only of plasma concentration and glomerular filtration rate,57t58 active renal tubular transport mechanisms for catecholamines are possible.5gp60 However, if plasma norepinephrine concentration is estimated by a reverse clearance technique, based on urinary norepinephrine excretion rate and glomerular filtration rate,57,58 a figure is obtained that agrees very closely with the value determined by direct double isotope derivative assay of norepinephrine in plasma. 57 Catecholamine levels in plasma and urine have been studied extensively in established essential hypertension.
There is now fairly general agreement that an elevated norepinephrine concentration in plasma and an increased norepinephrine excretion in urine can be demonstrated in a proportion of patients with essential hypertension.18,57,61762 In borderline hypertension the situation is less clear. Both Nestel and DoyleI and Kuschke17 reported elevated urinary catecholamine excretion in patients with borderline hypertension.
But this finding was not confirmed in a later study.57 DeQuattro and Chan18 noted an elevated plasma catecholamine concentration in only a minority of patients with borderline hypertension.
Louis et a1.62 noted a raised plasma norepinephrine concentration in patients with established essential hypertension, but not in a small number of those with borderline hypertension.
These conflicting findings in resting patients have prompted studies on the responsiveness to stimuli that activate the sympathetic nervous system. Excessive catecholamine responsiveness to mental stressI and to postural stimulation20T58 has been reported in borderline hypertension. But interpretation of these findings of increased sympathetic responsiveness is difficult. The paradox is that noradrenergic responsiveness appears to be completely unrelated to the norepinephrine levels at rest, in hypertension57; thus it is hard to infer that the stimulus functioned to expose an underlying, but difficult to demonstrate, state of sympathetic nervous overactivity.
It can be concluded that elevated plasma catecholamine concentrations and urinary catecholamine excretion probably exist in a proportion of patients with borderline hypertension, and that sympathetic overresponsiveness to some adrenergic stimuli probably occurs in a sizable minority. The significance of the blood pressure and catecholamine overresponsiveness is uncertain, but it has often been presumed that repeated pressor responses, in both human and animal prehypertension,63 may possibly lead to the subsequent development of permanent hypertension.
Dopamine-beta-hydroxylase: This enzyme, responsible for the conversion of dopamine to norepinephrine, is stored in *vesicles in sympathetic nerve Although the autoregulation from a high output to a high resistance state has not been adequately documented in man,73"74 the pivotal role that the heart may play in hypertension enhances the investigative interest in the mechanism of the elevation in cardiac output. We have been active in assessing the role of the autonomic nervous system.75 It can be seen from Figure 5 that cardiac output is increased in a sizable proportion of patients with borderline hypertension, but not in all. Patients with a substantial increase in cardiac output were selected for study and the role of the autonomic nervous system in the generation of this increase was investigated. The autonomic control of the heart was removed by intravenous injections of propranolol (0.2 mg/kg body weight) and atropine (0.04 mg/kg) (Fig. 6 ). With autonomic cardiac blockade, cardiac output levels fell into the normal range. Apparently the increased cardiac output was sustained by a neurogenic mechanism. The role of the autonomic nervous system in cardiac control can be better understood when heart rate and stroke volume are analyzed separately. The heart rate in patients was increased (Fig. 6 ). After autonomic influences on the heart were removed, heart rate became normal. Thus there is no evidence that the intrinsic pacemaker in "hyperkinetic" borderline hypertension is overactive; the increased heart rate resulted solely from neurogenic influences.
Stroke volume is also increased in patients with "hyperkinetic" borderline hypertension (Fig. 6 ). Such an increase in stroke volume could potentially be due to neurogenic or humoral influences on myocardial contractility, to enhanced "intrinsic" contractile properties of the myocardium in borderline hypertension or to volume loading of the left ventricle (increased venous filling of the heart).
The question of possible increased venous filling leading to a high stroke volume in patients with borderline hypertension was investigated. Cardiopulmonary ("central") blood volume was used as an index of cardiac filling. Central blood volume correlates strongly with stroke volume under a wide range of circumstances43p44,76-7g; this relation between central blood volume and stroke volume is taken to validate central blood volume measurements as an index of left ventricular filling. The elevation of stroke volume in borderline hypertension was claimed by Safar et
a1.47 to stem from an increased central blood volume. However, Ellis and Julius43 have shown that at similar levels of central blood volume, patients with "hyperkinetic" borderline hypertension have significantly higher stroke volumes than control subjects. This has been confirmed by Tarazi et a1.,44 who found an increased ratio of the stroke volume to central blood volume in borderline hypertension.
Apparently in borderline hypertension there is an enhanced stroke volume response to venous filling. This enhanced response is neurogenid. This can be seen from Figure 6 ; after autonomic blockade of the heart, normalization of stroke volume followed. Further, after autonomic blockade the relation of stroke volume and central blood volume in "hyperkinetic" borderline hypertension becomes normal (Fig. 7) .
In summary, the elevation of the cardiac output in patients with borderline hypertension stems from neurogenic influences on the heart.
Abnormalities of Total Peripheral Resistance
Total peripheral vascular resistance is normal at rest in "hyperkinetic" borderline hypertension.28p31132 However, it must be appreciated that under normal circumstances, when blood flow increases, there is an appropriate decrease in vascular resistance so that blood pressure remains unchanged. In "hyperkinetic" borderline hypertension the elevated blood pressure stems from an inappropriate adjustment of the peripheral resistance to the increased tissue perfusion accompanying the increased cardiac output.48 This underlying abnormality of the peripheral resistance can be further brought to light if stimuli are applied that normally lead to a decrease in vascular resistance. Thus during mild exercise31z48 and plasma vol- Rest 600 600 1000 1200
Blockade! CENTRAL BLOOD VOLUME INDEX ml/m 2 ume expansion,48 a subnormal decrease in peripheral resistance is observed in patients with borderline hypertension. Whereas in "hyperkinetic" borderline hypertension experimental maneuvers must be employed to demonstrate the abnormality in vascular resistance, in subjects with borderline hypertension and a normal cardiac output, total peripheral resistance is in. creased at rest.sOJO This increased resistance in borderline hypertension may well represent in part a structural impediment to flow, as suggested by Conway.80 He found that under conditions of maximal vasodilation patients with even very mild hypertension failed to increase their forearm blood flow to the same degree as normotensive subjects.
The question of a possible neurogenic basis for the abnormality in vascular resistance in borderline hypertension was studied by us in a group of patients with normal cardiac output and increased peripheral resistance at rest. The change in total peripheral resistance produced by intravenous injection of the alpha adrenergic blocking drug phentolamine (15 mg), after prior pharmacologic blockade of the heart., was investigated. s2,s1 As in normal subjects, in the majority of patients with borderline hypertension the peripheral resistance decreased very little. However, in approximately 30 percent of patients an immediate large reduction in peripheral resistance occurred, with normalization of the blood pressure. It appears that in a proportion of patients with borderline hypertension the elevated total peripheral vascular resistance is maintained by increased alpha adrenergic vasoconstrictor tone.
To summarize, in patients with "hyperkinetic" borderline hypertension total peripheral resistance is
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The American Journal of CARDIOLOGY Volume 36 FIGURE 7. Relation between the stroke volume index and the central blood volume index in 17 young male patients with increased cardiac output and in 49 normal subjects. Symbols as in Figure 6 . Mean central blood volume in normal subjects was used to form two groups ("low" and "high" central blood volume within normal limits, but inappropriately high for the level of cardiac output. In borderline hypertension with normal cardiac output, the increased peripheral resistance may in some cases be due to a structural (nonneurogenic) impediment to flow. However, in a proportion of patients there is evidence of enhanced alpha adrenergic vasomotor tone.
Venous Function in Borderline Hypertension
-4s discussed earlier in this review, central blood volume measurements reflect the dynamic relation between total blood volume, peripheral venous capacity and cardiopulmonary vascular distensibility. I_Urych et al.7H reported that patients with hypertension maintain a higher proportion of the total blood volume in the cardiopulmonary (central) capacity space than normal subjects. In a later work from the same laboratory, Tarazi et a1.44 found a high central blood volume in renovascular hypertension but not in borderline and essential hypertension.
Safar et a1.47 found central blood volume to be elevated in borderline hypertension.
This discrepancy among various studies may in part be a result of selection of patients. Thus in our laboratory, in "hyperkinetic" borderline hypertension 43 the central blood volume was marginally elevated (P <0.06), whereas in the overall population with borderline hypertension average values for central blood volume were normal. However, in subjects with borderline hypertension and low plasma renin activity central blood volume is distinctly elevated. 82 In patients with a demonstrable increased central blood volume, the relation of peripheral vascular capacity to cardiopulmonary vascular compliance is distorted in the direction of reduced peripheral ve-nous distensibility.
Such a restriction of peripheral venous capacity could stem from increased alpha adrenergic stimulation of veins. However, attempts to demonstrate increased alpha adrenergic venomotor tone in borderline hypertension have failed. In a small group of patients studied in our laboratory, in whom central blood volume at rest was elevated, administration of the alpha adrenergic blocking drug phentolamine (15 mg intravenously) failed to reduce central blood volume to normal limits.s2 These preliminary results do not support a neurogenic basis for the elevated central blood volume but must be interpreted with caution. A rather large dose of phentolamine may be required to accomplish alpha adrenergic blockade of veins.s3
Decreased plasma volume has been reported in borderline hypertension.
The mechanism is unexplained but could be related to excess sympathetic activity. Thus it is known that stimuli, such as hypoxia, that greatly increase sympathetic nervous activity decrease plasma volume and increase venous tone.s4 Apparently the increased sympathetic discharge causes postcapillary venoconstriction, leading to increased capillary filtration. Similarly, infusion of sympathomimetic amines causes a reduction in plasma volume by increasing postcapillary venous resistance, with consequent elevation of the capillary filtration index. 85 Conceivably such a sympathetically mediated increase in the capillary filtration index may be present in borderline hypertension. This hypothesis awaits experimental testing.
In summary, there is indirect evidence for increased venomotor tone in patients with borderline hypertension, but any possible relation between venous tone and increased sympathetic activity is yet to be clarified.
Plasma Renin Activity
Plasma renin activity at rest is elevated in some patients with borderline hypertension.14,20p2g In early studies14y20 dietary sodium intake was not assessed or controlled, so the finding was perhaps open to question. Subsequent investigations, performed under conditions of known sodium consumption, have confirmed the existence of high plasma renin activity in a proportion of patients with borderline hypertension.2gB52 Mohlzan et al. 2g found elevated plasma renin values at rest in patients with "hyperkinetic" borderline hypertension.
Recently in our laboratory plasma renin activity was found to be elevated in 30 percent of patients with borderline hypertension.52 Stimulated renins may also be increased in borderline hypertension.
Some patients show an excessive increase in plasma renin with head-up tilt or standing.20,51,53 Th e importance of renal sympathetic nerves in the control of renin release is well known. 86 The question arises whether increased sympathetic tone and high plasma renin activity in borderline hypertension are associated phenomena.
One line of evidence explores the relation of sympathetic nervous and renin responsiveness to orthostatic stimulation.
Kuchel et aLs7 reported signifi- cantly greater orthostatic increases in plasma renin activity and urinary norepinephrine in subjects with borderline hypertension than in control subjects. Esler and Neste120 observed a similar overresponsiveness to tilt.. In addition, a positive correlation between changes in plasma renin and urinary norepinephrine was noted.
Another line of evidence bears on the relation of sympathetic tone at rest to renin status in borderline hypertension. We recently reported a finding of increased adrenergic vasomotor tone in high renin borderline hypertension. 52 In response to alpha adrenergic blockade with intravenous phentolamine, patients with borderline hypertension and elevated plasma renin activity demonstrated an abnormally large reduction in total peripheral vascular resistance and blood pressure. That in such patients the sympathetic tone, and not the elevated renin level, is directly involved in the maintenance of the increase in blood pressure can be seen from Figure 8 .s8 After an injection of propranolol plasma renin activity decreased substantially, but blood pressure remained unchanged. The administration of phentolamine then caused an immediate decrease in blood pressure without further reduction in plasma renin activity.
Additional recent data indicate that the increased sympathetic drive involves the heart also; intravenously administered propranolol causes a greater reduction in heart rate in patients with high renin borderline hypertension than in normal subjects.8g Thus, the elevation of plasma renin activity appears to be only another facet of a widely distributed increase in sympathetic tone in borderline hypertension.
Receptor Sensitivity and Vascular Reactivity
In summary, some patients with borderline hypertension have elevated resting plasma renin activity. The renin responsiveness to orthostatic stimulation also is increased in a proportion of patients with borderline hypertension, There is evidence that the increased plasma renin activity in such patients is associated with nervous system overactivity.
The functional activity of an organdepends on the interaction between the excitatory and inhibitory autonomic impulses to which it is subjected, and the responsiveness of the organ. Consequently, apparent sympathetic overactivity observed in patients with borderline hypertension could stem from increased responsiveness to an essentially normal level of sympathetic nervous discharge.
Mechanism of the Autonomic Nervous Abnormality
In the previous section evidence was presented documenting abnormality of the autonomic nervous system in borderline hypertension.
Possible mechanisms responsible for such changes in autonomic control of the circulation require elucidation.
Abnormal Norepinephrine Dynamics at Sympathetic Nerve Endings
The sensitivity of beta adrenergic receptors in borderline hypertension has been evaluated in several ways. Kuchel et al. 87 studied biochemical responses to prolonged infusion of a beta adrenergic agonist (isoproterenol) in borderline hypertension. The increases in plasma renin activity and urinary cyclic adenosine monophosphate excretion were greater than in normal subjects. The subjects with borderline hypertension were believed to show beta receptor hyperresponsiveness to isoproterenol, but it is not clear whether the larger changes in these patients in plasma renin activity or cyclic adenosine monophosphate signify (1) altered receptor sensitivity, or (2) differential effects of isoproterenol on blood flow distribution and metabolic clearance rates of renin and cyclic adenosine monophosphate.
Even with normal rates of sympathetic nervous discharge, disturbances of the mechanisms of norepinephrine inactivation after its release at the sympathetic nerve terminals could produce the manifestations of "sympathetic nervous system overactivity" catalogued in this review. Released norepinephrine is subject to active reuptake into the nerve terminals, diffusion into the circulation and local enzymatic destruction by catechol-o-methyltransferase.5" Any factor that impairs removal of norepinephrine from the synaptic cleft intensifies and prolongs the adrenergic response to nervous discharge.
A beta adrenergic receptor hypersensitivity is inferred in patients with "hyperdynamic beta adrenergic circulatory" state.g2xg3 The diagnostic hallmark of this condition is an excessive' rise in the heart rate with short-term infusion of isoproterenol. Some, but not all, of these patients described by Frohlich et a1.g2 have borderline hypertension.
In human hypertension, most attention has been directed to the possibility that neuronal reuptake of norepinephrine may be defective or that catechol-omethyltransferase activity may be diminished. Evidence of defective norepinephrme reuptake in essential hypertension has been reviewed by Mendlowitz et aLgo The evidence is suggestive but indirect. and not conclusive. The question of norepinephrine reuptake has not been studied specifically in borderline hypertension. Perhaps a guide to catechol-o-methyltransferase activity and norepinephrine methylation is the normetanephrine:norepinephrine excretion rate in urine. Brunjes"' found no evidence of diminished norepinephrine o-methylation in essential hypertension using this criterion. Catechol-o-methyltransferase activity has not been studied in borderline hypertension.
Cardiac beta adrenergic hypersensitivity is not present in the majority of patients with "hyperkinetic" borderline hypertension.
Thus, Frohlich et alI4 did not find exaggerated heart rate and cardiac output responses to infusion of isoproterenol in 11 patients with borderline hypertension who had normal resting heart rates but whose cardiac output was elevated. In our study, six patients with "hyperkinetic" borderline hypertension had resting tachycardia, but had a subnormal heart rate response to isoproterenoL5" In a recent paper, Ibrahim et a1.g4 described patients with established hypertension who maintained an elevated level of cardiac output. Only a small fraction of them exhibited increased cardiac responsiveness to isoproterenol.
Sensitive methods for studying in man the dynamics of norepinephrine released at sympathetic varicosities are not available. The possibility that the observed manifestations of sympathetic overactivity in borderline hypertension are due to defective norepinephrine reuptake or subnormal catechol-o-methyltransferase activity remains open.
The possible presence of vascular hyperreactivity in borderline hypertension must also be considered. Thus it has been reported that some patients with borderline hypertension show a greater response of blood pressure or vascular resistance to such stimuli as tilt,20,g5 mental arithmeticI and lower body negative pressure.g6 All these responses are presumably mediated by the nervous system and were taken as an indicator of sympathetic overactivity in borderline hypertension.
However, this assumption can be accepted only if patients' blood vessels respond to sympathetic stimulation in a normal fashion.
There is limited evidence of possible vascular hyperreactivity in borderline hypertension. Doyle and Fraserg7 studied forearm vascular responsiveness to intraarterial norepinephrine in normotensive offspring of hypertensive parents. Compared with sons of parents with normal blood pressure, the offspring of hypertensive parents exhibited increased vascular reactivity to norepinephrine.
Suck et a1.g8 utilized digital plethysmography to assess vascular reactivity to norepinephrine in 18 patients with borderline hypertension. Increased vascular reactivity was found in 50 percent of those patients.
E. *** \
The question of vascular reactivity in borderline hypertension is not solved. Future research is needed to assess the prevalence of hyperreactivity in a large unselected population of patients with borderline hypertension, and to determine the relation between measures of vascular reactivity and indexes of sympathetic activity.
In summary, beta adrenergic hypersensitivity and vascular hyperreactivity have been described in patients with borderline hypertension. Beta adrenergic hypersensitivity appears to be infrequent. Vascular hyperreactivity perhaps exists and may possibly contribute to the pressor hyperresponsiveness recorded in borderline hypertension.
Abnormal Integration of Autonomic Nervous Control
We believe that in a majority of patients with borderline hypertension who show signs of abnormal autonomic regulation, the disorder originates in integrative areas of the medulla oblongata.75 Figure 4 shows that biochemical indexes of sympathetic activity are increased and that the increased net autonomic drive is distributed to various organ systems, and involves both alpha and beta adrenergic receptors. Such a generalized enhancement of sympathetic activity most likely originates in the central nervous system. In addition to sympathetic hyperactivity, changes in parasympathetic function have also been found in borderline hypertension.36 It can be seen in Figure 9 that in "hyperkinetic" borderline hypertension beta adrenergic blockade alone with intravenously administered propranolol was not sufficient to reduce cardiac output into the normal range. Only after parasympathetic blockade with atropine did the cardiac output become normal. Thus, both the sympathetic and parasympathetic control of the heart were involved in the elevation of cardiac output. After propranolol, cardiac output decreased more in patients than in control subjects, an indication of greater cardiac sympathetic drive in the subjects with borderline hypertension.
Conversely, after administration of atropine, patients responded with a smaller increase in cardiac output, signifying a diminished degree of cardiac parasympathetic inhibition. Such a reciprocal relation, in which increased sympathetic discharge is coupled with a decreased parasympathetic inhibition, is characteristic of the functional organization in the higher integrative areas of autonomic control.
REST PROPRANOLOL ATROPINE The cause of any existing functional changes in central nervous integrative areas in borderline hypertension is not readily evident, but a few possible mechanisms can be investigated.
One such mechanism involves the functioning of the arterial baroreceptors; these are the source of one of the main modifying inputs converging on centers in the medulla oblongata. The baroreceptor control system could possibly be set by an unidentified peripheral or central mechanism to allow higher resting sympathetic tone and decreased vagal inhibition. However, the rate of baroreceptor discharge cannot be adequately tested in human beings although the sensitivity of the arterial baroreceptors to acute blood pressure changes can be determined. Gribbin et aLgg observed reduced baroreflex sensitivity in some patients with borderline hypertension.
We75 were unable to reproduce this finding, but Takeshita et al.loo recently confirmed Gribbin's observation. Consequently, the evidence is in favor of a reduction in arterial baroreflex sensitivity in borderline hypertension. Birkenhager et al.lol described excessive blood pressure variability has not yet been delineated. Future research must be oriented toward identifying patients in whom all abnormalities are neurogenic. It is likely that such a fully neurogenic mechanism will be demonstrated only in a minority of patients. The evaluation of the natural history of this subset of "neurogenie" borderline hypertension in relation to the subsequent development of established hypertension and to the later presence or absence of identifiable neurogenic abnormality will represent a highly interesting and potentially rewarding topic for study. 5.
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